October 02, 2017
Pfizer Inc. fell short of proving the disclosure of its drug pricing and rebate information to two state legislators by the Texas Health and Human Services Commission was a violation of the Federal Medicaid Confidentiality Provision, a federal judge in Texas found on Friday, denying the pharmaceutical giant's bid for an injunction against the commission.
January 23, 2017
Pzifer Inc. told a federal judge in Texas on Friday that, contrary to claims from the Texas Health and Human Services Commission, there is no proof that the commission's disclosure of its drug pricing and rebate information to two state legislators was required in order to oversee administration of the Medicare rebate program.
January 06, 2017
The Texas Health and Human Services Commission on Friday told a Texas federal court that it didn't violate any laws by providing Pfizer Inc.'s drug pricing and rebate information to two state legislators because the public information act provides explicit exceptions for lawmakers.
November 17, 2016
Pfizer Inc. sued Texas' health agency in federal court Thursday, claiming it violated confidentiality rules intended to protect Pfizer's trade secret pricing and rebate information as part of the state's Medicaid program when it provided the sensitive data to state lawmakers.